Clinical Efficacy, Cosmetic Acceptability, and Local Tolerability of a New Formulation of Topical 5% Minoxidil Without Propylene Glycol: A 6-Month, Multicentre, Real-Life, Prospective, Assessor-Blinded Study in 196 Subjects with Hair Loss. The NOMINAL Trial
January 2021
in “
Journal of clinical & experimental dermatology research
”
TLDR The new 5% minoxidil formulation without propylene glycol effectively promotes hair growth with fewer side effects and better user satisfaction.
The "NOMINAL" trial evaluated the clinical efficacy, cosmetic acceptability, and local tolerability of a new 5% minoxidil formulation without propylene glycol over 6 months in 196 subjects with hair loss. The study found that the new formulation was effective in promoting hair growth, with significant improvements observed in hair density and thickness. Participants reported high levels of cosmetic acceptability, noting less greasiness and better overall satisfaction compared to traditional formulations. Additionally, the new formulation demonstrated good local tolerability, with fewer reports of scalp irritation and other side effects. These findings suggested that the new minoxidil formulation could be a viable alternative for individuals experiencing hair loss.